Hyperbaric oxygen therapy shows promise in IBD
29th April 2014
By Hugo Wilcken
Hyperbaric oxygen therapy (HBOT) is safe and potentially effective in treating patients with inflammatory bowel disease, say the US authors of a new systematic review.
Pooled data from 17 studies involving over 600 patients and 9000 HBOT sessions showed an overall response rate of around 86% in both Crohn’s and ulcerative colitis.
For UC patients with reported endoscopic follow-up of disease activity after treatment, the response rate was 100%, the investigators from the Dartmouth-Hitchcock Medical Center in New Hampshire